Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy.

Miri, Seyed Mohammad; Tafsiri, Elham; Cho, William Chi Shing; Ghaemi, Amir.

Afiliação

Miri SM; Department of Virology, Pasteur Institute of Iran, Tehran, Iran.
Tafsiri E; Molecular Medicine Department, Pasteur Institute of Iran, Biotechnology Research Center, Tehran, Iran.
Cho WCS; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China.
Ghaemi A; Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

Cancer Cell Int ; 20: 521, 2020.

Article em En | MEDLINE | ID: mdl-33132758

ABSTRACT

[This corrects the article DOI 10.1186/s12935-020-01546-8.].

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article